-
Net income was $3.16 per share, including net negative adjustment
items of $0.21 per share. Adjusted net income was $3.37 per share
(refer to the GAAP reconciliation table).
-
Medical enrollment has increased by approximately 0.5 million
members in 2017, or 1.2%, totaling approximately 40.4 million members
as of June 30, 2017.
-
Company expects medical enrollment to grow by nearly 300 - 500
thousand members for the full year 2017.
-
Full year 2017 GAAP net income is now expected to be greater than
$10.35. Full year adjusted net income is now expected to be greater
than $11.70 (refer to the GAAP reconciliation table).
-
Company increased its third quarter 2017 dividend to shareholders
by $0.05 per share to $0.70 per share.
INDIANAPOLIS--(BUSINESS WIRE)--Jul. 26, 2017--
Anthem, Inc. (NYSE: ANTM) today announced that second quarter 2017 net
income was $855.3 million, or $3.16 per share. These results included
net negative adjustment items of $0.21 per share. Net income in the
second quarter of 2016 was $780.6 million, or $2.91 per share, which
included net negative adjustment items of $0.42 per share.
Excluding the items noted in each period, adjusted net income was $3.37
per share in the second quarter of 2017 compared to the adjusted net
income of $3.33 per share in the prior year quarter (refer to the GAAP
reconciliation table for the most directly comparable measure calculated
in accordance with U.S. generally accepted accounting principles, or
“GAAP”).
“I am pleased with our second quarter 2017 results, carrying forward our
operating momentum. Our commitment to improving the quality and
affordability of health care for our customers is resonating in the
marketplace and benefiting our shareholders," said Joseph Swedish,
president and chief executive officer.
“Our solid second quarter financial results reflect solid performance
across our various business segments, which is reflected in our updated
2017 outlook,” said John Gallina, executive vice president and chief
financial officer.
CONSOLIDATED HIGHLIGHTS
Membership: Medical enrollment totaled approximately 40.4 million
members at June 30, 2017, an increase of 0.6 million members, or 1.6
percent, from 39.8 million at June 30, 2016. Commercial & Specialty
Business enrollment increased by 389 thousand medical members as the
Company experienced growth in both fully insured and self-funded Local
Group businesses, partially offset by a decline in membership in the
National Account and Individual businesses. Enrollment also grew by 193
thousand in the Medicaid business and 58 thousand in the Medicare
business.
Medical enrollment increased by 468 thousand during the first six months
of 2017. Enrollment gains were primarily in the Local Group, Individual,
and Medicare businesses.
Operating Revenue: Operating revenue was $22.2 billion in the
second quarter of 2017, an increase of $0.9 billion, or 4.3 percent,
versus the $21.3 billion in the prior year quarter. The growth in
revenue reflected premium rate increases to cover overall cost trends
across our business. Additionally, the increase was driven by higher
enrollment in the Local Group insured and self-funded businesses, as
well as in Medicaid and Medicare. These increases were partially offset
by the impact of the one year waiver of the health insurance tax in 2017
and less favorable adjustments to the prior year risk adjustment
estimates.
Benefit Expense Ratio: The benefit expense ratio was 86.1
percent in the second quarter of 2017, an increase of 190 basis points
from 84.2 percent in the prior year quarter. The increase, as expected,
was largely driven by the impact of the one year waiver of the health
insurance tax in 2017 and less favorable adjustments to the prior year
risk adjustment estimates. The increase was partially offset by improved
medical cost performance in the Local Group and Individual businesses.
Medical claims reserves established at December 31, 2016 developed
moderately better than the Company’s expectation during the first six
months of 2017.
Medical Cost Trend: For the full year 2017, the Company
continues to expect underlying Local Group medical cost trend to be in
the range of 6.5% - 7.0%.
Days in Claims Payable: Days in Claims Payable (“DCP”) was
40.5 days as of June 30, 2017, a decrease of 0.1 days from 40.6 days as
of March 31, 2017.
SG&A Expense Ratio: The SG&A expense ratio was 13.8 percent
in the second quarter of 2017, a decrease of 20 basis points from 14.0
percent in the second quarter of 2016. The decrease, as expected, was
primarily driven by the impact of the one year waiver of the health
insurance tax in 2017, the impact of operating expense efficiency
initiatives taken by the company, and fixed cost leverage on operating
revenue growth. The decrease was partially offset by higher
performance-based incentive compensation accruals and the 2015 cyber
attack litigation settlement recorded during the quarter.
Operating Cash Flow: Operating cash flow was $393 million, or 0.5
times net income in the second quarter of 2017, and approximately $3.1
billion, or 1.7 times net income for the first six months of 2017. The
Company continues to expect its full year 2017 operating cash flow to be
greater than $3.5 billion.
Share Repurchase Program: During the second quarter of 2017, the
Company repurchased 2.5 million shares of its common stock for $0.5
billion, or a weighted-average price of $182.83. During the first six
months of 2017, the Company repurchased 2.8 million shares of its common
stock for $0.5 billion, or a weighted average price of $180.37. As of
June 30, 2017, the Company had approximately $3.7 billion of
Board-approved share repurchase authorization remaining.
Cash Dividend: During the second quarter of 2017, the Company
paid a quarterly dividend of $0.65 per share, representing a
distribution of cash totaling $171.8 million.
On July 25, 2017, the Audit Committee declared a third quarter 2017
dividend to shareholders of $0.70 per share, an increase of $0.05 per
share from the second quarter dividend. On an annualized basis, this
equates to a dividend of $2.80 per share. The third quarter dividend is
payable on September 25, 2017 to shareholders of record at the close of
business on September 8, 2017.
Investment Portfolio & Capital Position: During the second
quarter of 2017, the Company recorded net realized gains on financial
instruments totaling $16.2 million and other-than-temporary impairment
losses totaling $7.2 million. During the second quarter of 2016, the
Company recorded net realized gains of $12.5 million and
other-than-temporary impairment losses totaling $25.7 million.
As of June 30, 2017, the Company’s net unrealized gain position in the
investment portfolio was $846.3 million, consisting of net unrealized
gains on equity and fixed maturity securities totaling $450.5 and $395.8
million, respectively. As of June 30, 2017 cash and investments at the
parent company totaled approximately $2.8 billion.
REPORTABLE SEGMENTS
Anthem, Inc. has three reportable segments: Commercial & Specialty
Business (comprised of the Local Group, National Accounts, Individual
and Specialty businesses); Government Business (comprised of the
Medicaid and Medicare businesses, National Government Services, and the
Federal Employee Program); and Other (comprised of unallocated corporate
expenses and certain other businesses that do not meet the quantitative
thresholds for separate reportable segment disclosure).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anthem, Inc.
|
|
|
Reportable Segment Highlights
|
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
Three Months Ended June 30
|
|
Six Months Ended June 30
|
|
|
|
|
2017
|
|
2016
|
|
Change
|
|
2017
|
|
2016
|
|
Change
|
|
|
Operating Revenue
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial & Specialty Business
|
|
$10,308.8
|
|
|
$9,898.3
|
|
|
4.1
|
%
|
|
$20,598.4
|
|
|
$19,408.1
|
|
|
6.1
|
%
|
|
|
Government Business
|
|
11,883.4
|
|
|
11,371.1
|
|
|
4.5
|
%
|
|
23,909.1
|
|
|
22,165.0
|
|
|
7.9
|
%
|
|
|
Other
|
|
5.8
|
|
|
5.1
|
|
|
13.7
|
%
|
|
10.0
|
|
|
10.8
|
|
|
(7.4
|
)%
|
|
|
Total Operating Revenue1 |
|
$22,198.0
|
|
|
$21,274.5
|
|
|
4.3
|
%
|
|
$44,517.5
|
|
|
$41,583.9
|
|
|
7.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Gain / (Loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial & Specialty Business
|
|
$967.9
|
|
|
$1,075.3
|
|
|
(10.0
|
)%
|
|
$2,270.3
|
|
|
$2,368.3
|
|
|
(4.1
|
)%
|
|
|
Government Business
|
|
293.3
|
|
|
450.5
|
|
|
(34.9
|
)%
|
|
611.9
|
|
|
775.5
|
|
|
(21.1
|
)%
|
|
|
Other
|
|
(34.2
|
)
|
|
(25.6
|
)
|
|
NM
|
2
|
|
(69.8
|
)
|
|
(73.2
|
)
|
|
NM
|
2
|
|
|
Total Operating Gain1 |
|
$1,227.0
|
|
|
$1,500.2
|
|
|
(18.2
|
)%
|
|
$2,812.4
|
|
|
$3,070.6
|
|
|
(8.4
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Margin
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial & Specialty Business
|
|
9.4
|
%
|
|
10.9
|
%
|
|
(150)
|
bp
|
|
11.0
|
%
|
|
12.2
|
%
|
|
(120)
|
bp
|
|
|
Government Business
|
|
2.5
|
%
|
|
4.0
|
%
|
|
(150)
|
bp
|
|
2.6
|
%
|
|
3.5
|
%
|
|
(90)
|
bp
|
|
|
Total Operating Margin1 |
|
5.5
|
%
|
|
7.1
|
%
|
|
(160)
|
bp
|
|
6.3
|
%
|
|
7.4
|
%
|
|
(110)
|
bp
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
See “Basis of Presentation.”
|
|
(2)
|
"NM" = calculation not meaningful.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commercial & Specialty Business: Operating gain in the
Commercial & Specialty Business segment totaled $967.9 million in the
second quarter of 2017, a decrease of $107.4 million, or 10.0 percent,
from $1,075.3 million in the second quarter of 2016. The decrease was
driven by less favorable adjustments to the prior year risk adjustment
estimates, the one year waiver of the health insurance tax in 2017, and
higher performance-based incentive compensation accruals. The decrease
was partially offset by improved medical cost performance in the Local
Group and Individual businesses.
Government Business: Operating gain in the Government Business
segment was $293.3 million in the second quarter of 2017, a decrease of
$157.2 million, or 34.9 percent, from $450.5 million in the second
quarter of 2016. The decrease reflected higher performance-based
incentive compensation accruals and the impact of the one year waiver of
the health insurance tax in 2017.
Other: The Company reported an operating loss of $34.2 million in
the Other segment for the second quarter of 2017, compared with an
operating loss of $25.6 million in the prior year quarter.
OUTLOOK
Full Year 2017*:
-
Net income is expected to be greater than $10.35 per share, including
approximately $1.35 per share of net unfavorable items. Excluding
these items, adjusted net income is now expected to be greater than
$11.70 (refer to the GAAP reconciliation table).
-
Medical membership is expected to be in the range of 40,200,000 -
40,400,000. Fully insured membership is now expected to be in the
range of 15,200,000 - 15,300,000 and self-funded membership is
expected to be in the range of 25,000,000 - 25,100,000.
-
Operating revenue is now expected to be in the range of $88.5 - $89.5
billion.
-
Benefit expense ratio is expected to be in the range of 87.0% plus or
minus 30 basis points.
-
SG&A ratio is expected to be in the range of 13.6% plus or minus 30
basis points.
-
Operating cash flow is expected to be greater than $3.5 billion.
* This outlook includes the impact of the Penn Treaty assessments,
2015 cyber attack litigation settlement, and terminated Cigna
acquisition transaction costs incurred during the first half of 2017,
but does not include any transaction or legal costs associated with the
terminated Cigna acquisition beyond those incurred in the first half of
2017.
Basis of Presentation
-
Operating revenue and operating gain are the key measures used by
management to evaluate performance in each of its reporting segments,
allocate resources, set incentive compensation targets and to forecast
future operating performance. Operating gain is calculated as total
operating revenue less benefit expense and selling, general and
administrative expense. It does not include net investment income, net
realized gains/losses on financial instruments, other-than-temporary
impairment losses recognized in income, interest expense, amortization
of other intangible assets, gains/losses on extinguishment of debt or
income taxes, as these items are managed in a corporate shared service
environment and are not the responsibility of operating segment
management (refer to the GAAP reconciliation tables).
-
Operating margin is defined as operating gain divided by operating
revenue.
Conference Call and Webcast
Management will host a conference call and webcast today at 8:30 a.m.
Eastern Daylight Time (“EDT”) to discuss the company’s second quarter
results and outlook. The conference call should be accessed at least 15
minutes prior to the start of the call with the following numbers:
|
|
|
|
|
|
|
800-230-1092 (Domestic)
|
|
|
|
|
|
800-475-6701 (Domestic Replay)
|
|
|
|
|
|
|
|
612-288-0337 (International)
|
|
|
|
|
|
320-365-3844 (International Replay)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
An access code is not required for today’s conference call. The access
code for the replay is 403156. The replay will be available from 11:00
a.m. EDT today, until the end of the day on August 9, 2017. The call
will also be available through a live webcast at www.antheminc.com
under the “Investors” link. A webcast replay will be available following
the call.
About Anthem, Inc.
Anthem is working to transform health care with trusted and caring
solutions. Our health plan companies deliver quality products and
services that give their members access to the care they need. With over
74 million people served by its affiliated companies, including more
than 40 million enrolled in its family of health plans, Anthem is one of
the nation’s leading health benefits companies. For more information
about Anthem’s family of companies, please visit www.antheminc.com/companies.
|
Anthem, Inc.
|
|
Membership Summary
|
|
(Unaudited and in Thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change from
|
|
|
|
June 30,
|
|
June 30,
|
|
December 31,
|
|
June 30,
|
|
December 31,
|
|
Medical Membership
|
|
2017
|
|
2016
|
|
2016
|
|
2016
|
|
2016
|
|
Customer Type
|
|
|
|
|
|
|
|
|
|
|
|
Local Group
|
|
15,705
|
|
|
15,192
|
|
|
15,429
|
|
|
3.4
|
%
|
|
1.8
|
%
|
|
Individual
|
|
1,779
|
|
|
1,812
|
|
|
1,664
|
|
|
(1.8
|
)%
|
|
6.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
National:
|
|
|
|
|
|
|
|
|
|
|
|
National Accounts
|
|
7,760
|
|
|
7,808
|
|
|
7,741
|
|
|
(0.6
|
)%
|
|
0.2
|
%
|
|
BlueCard® |
|
5,561
|
|
|
5,604
|
|
|
5,550
|
|
|
(0.8
|
)%
|
|
0.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total National
|
|
13,321
|
|
|
13,412
|
|
|
13,291
|
|
|
(0.7
|
)%
|
|
0.2
|
%
|
|
Medicare
|
|
1,484
|
|
|
1,426
|
|
|
1,438
|
|
|
4.1
|
%
|
|
3.2
|
%
|
|
Medicaid
|
|
6,529
|
|
|
6,336
|
|
|
6,527
|
|
|
3.0
|
%
|
|
—
|
%
|
|
FEP
|
|
1,569
|
|
|
1,572
|
|
|
1,570
|
|
|
(0.2
|
)%
|
|
(0.1
|
)%
|
|
Total Medical Membership
|
|
40,387
|
|
|
39,750
|
|
|
39,919
|
|
|
1.6
|
%
|
|
1.2
|
%
|
|
Funding Arrangement
|
|
|
|
|
|
|
|
|
|
|
|
Self-Funded
|
|
24,938
|
|
|
24,550
|
|
|
24,688
|
|
|
1.6
|
%
|
|
1.0
|
%
|
|
Fully-Insured
|
|
15,449
|
|
|
15,200
|
|
|
15,231
|
|
|
1.6
|
%
|
|
1.4
|
%
|
|
Total Medical Membership
|
|
40,387
|
|
|
39,750
|
|
|
39,919
|
|
|
1.6
|
%
|
|
1.2
|
%
|
|
Reportable Segment
|
|
|
|
|
|
|
|
|
|
|
|
Commercial and Specialty Business
|
|
30,805
|
|
|
30,416
|
|
|
30,384
|
|
|
1.3
|
%
|
|
1.4
|
%
|
|
Government Business
|
|
9,582
|
|
|
9,334
|
|
|
9,535
|
|
|
2.7
|
%
|
|
0.5
|
%
|
|
Total Medical Membership
|
|
40,387
|
|
|
39,750
|
|
|
39,919
|
|
|
1.6
|
%
|
|
1.2
|
%
|
|
Other Membership
|
|
|
|
|
|
|
|
|
|
|
|
Life and Disability Members
|
|
4,705
|
|
|
4,689
|
|
|
4,732
|
|
|
0.3
|
%
|
|
(0.6
|
)%
|
|
Dental Members
|
|
5,818
|
|
|
5,413
|
|
|
5,486
|
|
|
7.5
|
%
|
|
6.1
|
%
|
|
Dental Administration Members
|
|
5,335
|
|
|
5,369
|
|
|
5,294
|
|
|
(0.6
|
)%
|
|
0.8
|
%
|
|
Vision Members
|
|
6,791
|
|
|
5,929
|
|
|
6,388
|
|
|
14.5
|
%
|
|
6.3
|
%
|
|
Medicare Advantage Part D Members
|
|
679
|
|
|
608
|
|
|
629
|
|
|
11.7
|
%
|
|
7.9
|
%
|
|
Medicare Part D Standalone Members
|
|
322
|
|
|
352
|
|
|
350
|
|
|
(8.5
|
)%
|
|
(8.0
|
)%
|
|
|
|
Anthem, Inc.
|
|
Consolidated Statements of Income
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
(In millions, except per share data)
|
|
June 30
|
|
|
|
|
|
2017
|
|
2016
|
|
Change
|
|
Revenues
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
20,813.1
|
|
|
$
|
19,948.0
|
|
|
4.3
|
%
|
|
Administrative fees
|
|
1,378.9
|
|
|
1,315.8
|
|
|
4.8
|
%
|
|
Other revenue
|
|
6.0
|
|
|
10.7
|
|
|
(43.9
|
)%
|
|
Total operating revenue
|
|
22,198.0
|
|
|
21,274.5
|
|
|
4.3
|
%
|
|
Net investment income
|
|
200.2
|
|
|
194.9
|
|
|
2.7
|
%
|
|
Net realized gains on financial instruments
|
|
16.2
|
|
|
12.5
|
|
|
29.6
|
%
|
|
Other-than-temporary impairment losses on investments:
|
|
|
|
|
|
|
|
Total other-than-temporary impairment losses on investments
|
|
(7.3
|
)
|
|
(33.8
|
)
|
|
(78.4
|
)%
|
|
Portion of other-than-temporary impairment losses recognized in
other comprehensive income
|
|
0.1
|
|
|
8.1
|
|
|
(98.8
|
)%
|
|
Other-than-temporary impairment losses recognized in income
|
|
(7.2
|
)
|
|
(25.7
|
)
|
|
(72.0
|
)%
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
22,407.2
|
|
|
21,456.2
|
|
|
4.4
|
%
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
Benefit expense
|
|
17,917.2
|
|
|
16,805.2
|
|
|
6.6
|
%
|
|
Selling, general and administrative expense:
|
|
|
|
|
|
|
|
Selling expense
|
|
345.5
|
|
|
351.5
|
|
|
(1.7
|
)%
|
|
General and administrative expense
|
|
2,708.3
|
|
|
2,617.6
|
|
|
3.5
|
%
|
|
Total selling, general and administrative expense
|
|
3,053.8
|
|
|
2,969.1
|
|
|
2.9
|
%
|
|
Interest expense
|
|
189.9
|
|
|
185.7
|
|
|
2.3
|
%
|
|
Amortization of other intangible assets
|
|
40.6
|
|
|
47.9
|
|
|
(15.2
|
)%
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
21,201.5
|
|
|
20,007.9
|
|
|
6.0
|
%
|
|
|
|
|
|
|
|
|
|
Income before income tax expense
|
|
1,205.7
|
|
|
1,448.3
|
|
|
(16.8
|
)%
|
|
|
|
|
|
|
|
|
|
Income tax expense
|
|
350.4
|
|
|
667.7
|
|
|
(47.5
|
)%
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
855.3
|
|
|
$
|
780.6
|
|
|
9.6
|
%
|
|
|
|
|
|
|
|
|
|
Net income per diluted share
|
|
$
|
3.16
|
|
|
$
|
2.91
|
|
|
8.6
|
%
|
|
|
|
|
|
|
|
|
|
Diluted shares
|
|
270.8
|
|
|
268.2
|
|
|
1.0
|
%
|
|
|
|
|
|
|
|
|
|
Benefit expense as a percentage of premiums
|
|
86.1
|
%
|
|
84.2
|
%
|
|
190bp
|
|
Selling, general and administrative expense as a percentage of total
operating revenue
|
|
13.8
|
%
|
|
14.0
|
%
|
|
(20)bp
|
|
Income before income taxes as a percentage of total revenue
|
|
5.4
|
%
|
|
6.8
|
%
|
|
(140)bp
|
|
|
|
Anthem, Inc.
|
|
Consolidated Statements of Income
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended
|
|
|
|
(In millions, except per share data)
|
|
June 30
|
|
|
|
|
|
2017
|
|
2016
|
|
Change
|
|
Revenues
|
|
|
|
|
|
|
|
Premiums
|
|
$
|
41,764.4
|
|
|
$
|
38,936.9
|
|
|
7.3
|
%
|
|
Administrative fees
|
|
2,742.1
|
|
|
2,626.8
|
|
|
4.4
|
%
|
|
Other revenue
|
|
11.0
|
|
|
20.2
|
|
|
(45.5
|
)%
|
|
Total operating revenue
|
|
44,517.5
|
|
|
41,583.9
|
|
|
7.1
|
%
|
|
Net investment income
|
|
407.4
|
|
|
366.0
|
|
|
11.3
|
%
|
|
Net realized gains (losses) on financial instruments
|
|
23.5
|
|
|
(112.6
|
)
|
|
(120.9
|
)%
|
|
Other-than-temporary impairment losses on investments:
|
|
|
|
|
|
|
|
Total other-than-temporary impairment losses on investments
|
|
(16.9
|
)
|
|
(119.0
|
)
|
|
(85.8
|
)%
|
|
Portion of other-than-temporary impairment losses recognized in
other comprehensive income
|
|
1.6
|
|
|
26.4
|
|
|
(93.9
|
)%
|
|
Other-than-temporary impairment losses recognized in income
|
|
(15.3
|
)
|
|
(92.6
|
)
|
|
(83.5
|
)%
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
44,933.1
|
|
|
41,744.7
|
|
|
7.6
|
%
|
|
|
|
|
|
|
|
|
|
Expenses
|
|
|
|
|
|
|
|
Benefit expense
|
|
35,460.0
|
|
|
32,344.0
|
|
|
9.6
|
%
|
|
Selling, general and administrative expense:
|
|
|
|
|
|
|
|
Selling expense
|
|
694.1
|
|
|
701.4
|
|
|
(1.0
|
)%
|
|
General and administrative expense
|
|
5,551.0
|
|
|
5,467.9
|
|
|
1.5
|
%
|
|
Total selling, general and administrative expense
|
|
6,245.1
|
|
|
6,169.3
|
|
|
1.2
|
%
|
|
Interest expense
|
|
424.9
|
|
|
372.8
|
|
|
14.0
|
%
|
|
Amortization of other intangible assets
|
|
82.4
|
|
|
98.3
|
|
|
(16.2
|
)%
|
|
|
|
|
|
|
|
|
|
Total expenses
|
|
42,212.4
|
|
|
38,984.4
|
|
|
8.3
|
%
|
|
|
|
|
|
|
|
|
|
Income before income tax expense
|
|
2,720.7
|
|
|
2,760.3
|
|
|
(1.4
|
)%
|
|
|
|
|
|
|
|
|
|
Income tax expense
|
|
855.5
|
|
|
1,276.7
|
|
|
(33.0
|
)%
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
1,865.2
|
|
|
$
|
1,483.6
|
|
|
25.7
|
%
|
|
|
|
|
|
|
|
|
|
Net income per diluted share
|
|
$
|
6.89
|
|
|
$
|
5.54
|
|
|
24.4
|
%
|
|
|
|
|
|
|
|
|
|
Diluted shares
|
|
270.6
|
|
|
267.8
|
|
|
1.0
|
%
|
|
|
|
|
|
|
|
|
|
Benefit expense as a percentage of premiums
|
|
84.9
|
%
|
|
83.1
|
%
|
|
180bp
|
|
Selling, general and administrative expense as a percentage of total
operating revenue
|
|
14.0
|
%
|
|
14.8
|
%
|
|
(80)bp
|
|
Income before income taxes as a percentage of total revenue
|
|
6.1
|
%
|
|
6.6
|
%
|
|
(50)bp
|
|
|
|
Anthem, Inc.
|
|
Consolidated Balance Sheets
|
|
|
|
|
|
June 30,
|
|
December 31,
|
|
(In millions)
|
|
2017
|
|
2016
|
|
Assets
|
|
(Unaudited)
|
|
|
|
Current assets:
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
4,561.2
|
|
|
$
|
4,075.3
|
|
|
Investments available-for-sale, at fair value:
|
|
|
|
|
|
Fixed maturity securities
|
|
18,948.2
|
|
|
17,163.1
|
|
|
Equity securities
|
|
1,823.8
|
|
|
1,468.5
|
|
|
Other invested assets, current
|
|
19.1
|
|
|
15.8
|
|
|
Accrued investment income
|
|
158.2
|
|
|
164.5
|
|
|
Premium and self-funded receivables
|
|
6,105.7
|
|
|
5,860.8
|
|
|
Other receivables
|
|
2,525.4
|
|
|
2,536.6
|
|
|
Income taxes receivable
|
|
—
|
|
|
168.7
|
|
|
Securities lending collateral
|
|
1,214.5
|
|
|
1,079.8
|
|
|
Other current assets
|
|
1,774.6
|
|
|
1,781.8
|
|
|
Total current assets
|
|
37,130.7
|
|
|
34,314.9
|
|
|
|
|
|
|
|
|
Long-term investments available-for-sale, at fair value:
|
|
|
|
|
|
Fixed maturity securities
|
|
524.8
|
|
|
524.4
|
|
|
Equity securities
|
|
32.3
|
|
|
31.4
|
|
|
Other invested assets, long-term
|
|
2,352.1
|
|
|
2,240.5
|
|
|
Property and equipment, net
|
|
1,975.7
|
|
|
1,977.9
|
|
|
Goodwill
|
|
17,561.2
|
|
|
17,561.2
|
|
|
Other intangible assets
|
|
7,882.4
|
|
|
7,964.9
|
|
|
Other noncurrent assets
|
|
778.4
|
|
|
467.9
|
|
|
Total assets
|
|
$
|
68,237.6
|
|
|
$
|
65,083.1
|
|
|
|
|
|
|
|
|
Liabilities and shareholders’ equity
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
Policy liabilities:
|
|
|
|
|
|
Medical claims payable
|
|
$
|
7,969.5
|
|
|
$
|
7,892.6
|
|
|
Reserves for future policy benefits
|
|
69.6
|
|
|
71.8
|
|
|
Other policyholder liabilities
|
|
2,447.5
|
|
|
2,221.1
|
|
|
Total policy liabilities
|
|
10,486.6
|
|
|
10,185.5
|
|
|
Unearned income
|
|
1,837.8
|
|
|
971.9
|
|
|
Accounts payable and accrued expenses
|
|
3,815.7
|
|
|
4,014.9
|
|
|
Income taxes payable
|
|
113.0
|
|
|
—
|
|
|
Security trades pending payable
|
|
227.8
|
|
|
93.5
|
|
|
Securities lending payable
|
|
1,213.7
|
|
|
1,078.9
|
|
|
Short-term borrowings
|
|
580.0
|
|
|
440.0
|
|
|
Current portion of long-term debt
|
|
624.4
|
|
|
928.4
|
|
|
Other current liabilities
|
|
3,668.9
|
|
|
3,581.3
|
|
|
Total current liabilities
|
|
22,567.9
|
|
|
21,294.4
|
|
|
|
|
|
|
|
|
Long-term debt, less current portion
|
|
15,088.0
|
|
|
14,358.5
|
|
|
Reserves for future policy benefits, noncurrent
|
|
619.0
|
|
|
666.1
|
|
|
Deferred tax liabilities, net
|
|
2,632.7
|
|
|
2,779.9
|
|
|
Other noncurrent liabilities
|
|
898.3
|
|
|
883.8
|
|
|
Total liabilities
|
|
41,805.9
|
|
|
39,982.7
|
|
|
|
|
|
|
|
|
Shareholders’ equity
|
|
|
|
|
|
Common stock
|
|
2.6
|
|
|
2.6
|
|
|
Additional paid-in capital
|
|
8,897.0
|
|
|
8,805.1
|
|
|
Retained earnings
|
|
17,667.0
|
|
|
16,560.6
|
|
|
Accumulated other comprehensive loss
|
|
(134.9
|
)
|
|
(267.9
|
)
|
|
Total shareholders’ equity
|
|
26,431.7
|
|
|
25,100.4
|
|
|
Total liabilities and shareholders’ equity
|
|
$
|
68,237.6
|
|
|
$
|
65,083.1
|
|
|
|
|
Anthem, Inc.
|
|
Consolidated Statements of Cash Flows
|
|
(Unaudited)
|
|
|
|
|
|
|
|
(In millions)
|
|
Six Months Ended June 30
|
|
|
|
2017
|
|
2016
|
|
Operating activities
|
|
|
|
|
|
Net income
|
|
$1,865.2
|
|
$1,483.6
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
Net realized (gains) losses on financial instruments
|
|
(23.5
|
)
|
|
112.6
|
|
|
Other-than-temporary impairment losses recognized in income
|
|
15.3
|
|
|
92.6
|
|
|
Loss on disposal of assets
|
|
0.4
|
|
|
0.6
|
|
|
Deferred income taxes
|
|
(209.9
|
)
|
|
99.7
|
|
|
Amortization, net of accretion
|
|
385.0
|
|
|
399.4
|
|
|
Depreciation expense
|
|
54.5
|
|
|
51.7
|
|
|
Share-based compensation
|
|
87.1
|
|
|
82.4
|
|
|
Excess tax benefits from share-based compensation
|
|
—
|
|
|
(46.0
|
)
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
Receivables, net
|
|
(134.7
|
)
|
|
(332.8
|
)
|
|
Other invested assets
|
|
(22.4
|
)
|
|
(13.2
|
)
|
|
Other assets
|
|
(322.4
|
)
|
|
(284.5
|
)
|
|
Policy liabilities
|
|
254.0
|
|
|
54.1
|
|
|
Unearned income
|
|
865.9
|
|
|
(312.7
|
)
|
|
Accounts payable and accrued expenses
|
|
(53.0
|
)
|
|
343.1
|
|
|
Other liabilities
|
|
81.5
|
|
|
(17.1
|
)
|
|
Income taxes
|
|
281.7
|
|
|
338.2
|
|
|
Other, net
|
|
(43.4
|
)
|
|
(22.3
|
)
|
|
Net cash provided by operating activities
|
|
3,081.3
|
|
|
2,029.4
|
|
|
|
|
|
|
|
|
Investing activities
|
|
|
|
|
|
Purchases of fixed maturity securities
|
|
(7,637.0
|
)
|
|
(5,509.3
|
)
|
|
Proceeds from sales and maturities of fixed maturity securities
|
|
6,119.3
|
|
|
4,836.8
|
|
|
Purchases of equity securities
|
|
(506.0
|
)
|
|
(1,032.3
|
)
|
|
Proceeds from sales of equity securities
|
|
214.7
|
|
|
486.4
|
|
|
Purchases of other invested assets
|
|
(162.3
|
)
|
|
(261.1
|
)
|
|
Proceeds from sales of other invested assets
|
|
121.8
|
|
|
219.4
|
|
|
Change in collateral and settlements of non-hedging derivatives
|
|
(2.1
|
)
|
|
14.7
|
|
|
Changes in securities lending collateral
|
|
(134.8
|
)
|
|
(211.2
|
)
|
|
Net purchases of property and equipment
|
|
(294.2
|
)
|
|
(251.2
|
)
|
|
Other, net
|
|
11.8
|
|
|
—
|
|
|
Net cash used in investing activities
|
|
(2,268.8
|
)
|
|
(1,707.8
|
)
|
|
|
|
|
|
|
|
Financing activities
|
|
|
|
|
|
Net proceeds from/(repayments of) commercial paper borrowings
|
|
1,347.8
|
|
|
(225.2
|
)
|
|
Net proceeds from/(repayments of) short-term borrowings
|
|
140.0
|
|
|
(100.0
|
)
|
|
Net repayments of long-term borrowings
|
|
(929.9
|
)
|
|
—
|
|
|
Changes in securities lending payable
|
|
134.8
|
|
|
211.1
|
|
|
Changes in bank overdrafts
|
|
(146.2
|
)
|
|
15.2
|
|
|
Repurchase and retirement of common stock
|
|
(509.0
|
)
|
|
—
|
|
|
Change in collateral and settlements of debt-related derivatives
|
|
(128.4
|
)
|
|
(467.5
|
)
|
|
Cash dividends
|
|
(344.0
|
)
|
|
(341.6
|
)
|
|
Proceeds from issuance of common stock under employee stock plans
|
|
151.0
|
|
|
71.7
|
|
|
Taxes paid through withholding of common stock under employee stock
plans
|
|
(45.6
|
)
|
|
(63.1
|
)
|
|
Excess tax benefits from share-based compensation
|
|
—
|
|
|
46.0
|
|
|
Net cash used in financing activities
|
|
(329.5
|
)
|
|
(853.4
|
)
|
|
|
|
|
|
|
|
Effect of foreign exchange rates on cash and cash equivalents
|
|
2.9
|
|
|
1.0
|
|
|
|
|
|
|
|
|
Change in cash and cash equivalents
|
|
485.9
|
|
|
(530.8
|
)
|
|
Cash and cash equivalents at beginning of year
|
|
4,075.3
|
|
|
2,113.5
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period
|
|
$4,561.2
|
|
$1,582.7
|
|
|
|
Anthem, Inc.
|
|
Reconciliation of Medical Claims Payable
|
|
|
|
|
|
Six Months Ended
|
|
|
|
|
|
June 30
|
|
Years Ended December 31
|
|
|
|
2017
|
|
2016
|
|
2016
|
|
2015
|
|
2014
|
|
(In millions)
|
|
(Unaudited)
|
|
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross medical claims payable, beginning of period
|
|
$
|
7,892.6
|
|
|
$
|
7,569.8
|
|
|
$
|
7,569.8
|
|
|
$
|
6,861.2
|
|
|
$
|
6,127.2
|
|
|
Ceded medical claims payable, beginning of period
|
|
(539.1
|
)
|
|
(645.6
|
)
|
|
(645.6
|
)
|
|
(767.4
|
)
|
|
(23.4
|
)
|
|
Net medical claims payable, beginning of period
|
|
7,353.5
|
|
|
6,924.2
|
|
|
6,924.2
|
|
|
6,093.8
|
|
|
6,103.8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Business combinations and purchase adjustments
|
|
—
|
|
|
—
|
|
|
—
|
|
|
121.8
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net incurred medical claims:
|
|
|
|
|
|
|
|
|
|
|
|
Current year
|
|
35,686.5
|
|
|
32,452.2
|
|
|
66,371.4
|
|
|
60,708.4
|
|
|
56,305.8
|
|
|
Prior years redundancies(1) |
|
(951.0
|
)
|
|
(726.3
|
)
|
|
(850.4
|
)
|
|
(800.2
|
)
|
|
(541.9
|
)
|
|
Total net incurred medical claims
|
|
34,735.5
|
|
|
31,725.9
|
|
|
65,521.0
|
|
|
59,908.2
|
|
|
55,763.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net payments attributable to:
|
|
|
|
|
|
|
|
|
|
|
|
Current year medical claims
|
|
28,540.4
|
|
|
26,197.1
|
|
|
59,156.6
|
|
|
54,067.7
|
|
|
50,353.9
|
|
|
Prior years medical claims
|
|
6,070.9
|
|
|
5,541.4
|
|
|
5,935.1
|
|
|
5,131.9
|
|
|
5,420.0
|
|
|
Total net payments
|
|
34,611.3
|
|
|
31,738.5
|
|
|
65,091.7
|
|
|
59,199.6
|
|
|
55,773.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net medical claims payable, end of period
|
|
7,477.7
|
|
|
6,911.6
|
|
|
7,353.5
|
|
|
6,924.2
|
|
|
6,093.8
|
|
|
Ceded medical claims payable, end of period
|
|
491.8
|
|
|
587.0
|
|
|
539.1
|
|
|
645.6
|
|
|
767.4
|
|
|
Gross medical claims payable, end of period
|
|
$
|
7,969.5
|
|
|
$
|
7,498.6
|
|
|
$
|
7,892.6
|
|
|
$
|
7,569.8
|
|
|
$
|
6,861.2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current year medical claims paid as a percentage of current year net
incurred medical claims
|
|
80.0
|
%
|
|
80.7
|
%
|
|
89.1
|
%
|
|
89.1
|
%
|
|
89.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prior year redundancies in the current year as a percentage of prior
year net medical claims payable less prior year redundancies in the
current year
|
|
14.9
|
%
|
|
11.7
|
%
|
|
14.0
|
%
|
|
15.1
|
%
|
|
9.7
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prior year redundancies in the current year as a percentage of prior
year net incurred medical claims
|
|
1.5
|
%
|
|
1.2
|
%
|
|
1.4
|
%
|
|
1.4
|
%
|
|
1.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Negative amounts reported for net incurred medical
claims related to prior years result from claims being settled for
amounts less than originally estimated.
|
|
Anthem, Inc.
|
|
GAAP Reconciliation
|
|
(Unaudited)
|
|
|
|
Anthem, Inc. has referenced “Adjusted Net Income” and “Adjusted Net
Income Per Share,” which are non-GAAP measures, in this document.
These non-GAAP measures are not intended to be alternatives to any
measure calculated in accordance with GAAP. In addition to these
non-GAAP measures, references are made to the measures “Operating
Revenue” and “Operating Gain.” Each of these measures is provided to
further aid investors in understanding and analyzing the company’s
core operating results and comparing Anthem, Inc.’s financial
results. A reconciliation of Operating Revenue to Total Revenue is
set forth in the Consolidated Statements of Income herein. A
reconciliation of the non-GAAP measures to the most directly
comparable measures calculated in accordance with GAAP, together
with a reconciliation of reportable segments operating gain to
income before income tax expense, is reported below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
Six Months Ended
|
|
|
|
|
|
June 30
|
|
|
|
June 30
|
|
|
|
(In millions, except per share data)
|
|
2017
|
|
2016
|
|
Change
|
|
2017
|
|
2016
|
|
Change
|
|
Net income
|
|
$
|
855.3
|
|
|
$
|
780.6
|
|
|
9.6
|
%
|
|
$
|
1,865.2
|
|
|
$
|
1,483.6
|
|
|
25.7
|
%
|
|
Add / (Subtract):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net realized (gains)/losses on financial instruments
|
|
(16.2
|
)
|
|
(12.5
|
)
|
|
|
|
(23.5
|
)
|
|
112.6
|
|
|
|
|
Other-than-temporary impairment losses recognized in income
|
|
7.2
|
|
|
25.7
|
|
|
|
|
15.3
|
|
|
92.6
|
|
|
|
|
Transaction related costs
|
|
51.2
|
|
|
79.2
|
|
|
|
|
150.9
|
|
|
174.7
|
|
|
|
|
Income tax true-up of prior transaction costs
|
|
(69.3
|
)
|
|
—
|
|
|
|
|
(69.3
|
)
|
|
—
|
|
|
|
|
2015 cyber attack litigation settlement
|
|
115.0
|
|
|
—
|
|
|
|
|
115.0
|
|
|
—
|
|
|
|
|
Amortization of other intangible assets
|
|
40.6
|
|
|
47.9
|
|
|
|
|
82.4
|
|
|
98.3
|
|
|
|
|
Penn Treaty assessment costs
|
|
—
|
|
|
—
|
|
|
|
|
253.8
|
|
|
—
|
|
|
|
|
Deferred tax asset write-off from California tax legislation
|
|
—
|
|
|
20.7
|
|
|
|
|
—
|
|
|
20.7
|
|
|
|
|
Tax impact of non-GAAP adjustments
|
|
(71.4
|
)
|
|
(48.2
|
)
|
|
|
|
(212.0
|
)
|
|
(164.0
|
)
|
|
|
|
Net adjustment items
|
|
57.1
|
|
|
112.8
|
|
|
|
|
312.6
|
|
|
334.9
|
|
|
|
|
Adjusted net income
|
|
$
|
912.4
|
|
|
$
|
893.4
|
|
|
2.1
|
%
|
|
$
|
2,177.8
|
|
|
$
|
1,818.5
|
|
|
19.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per diluted share
|
|
$
|
3.16
|
|
|
$
|
2.91
|
|
|
8.6
|
%
|
|
$
|
6.89
|
|
|
$
|
5.54
|
|
|
24.4
|
%
|
|
Add / (Subtract):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net realized (gains)/losses on financial instruments
|
|
(0.06
|
)
|
|
(0.05
|
)
|
|
|
|
(0.09
|
)
|
|
0.42
|
|
|
|
|
Other-than-temporary impairment losses recognized in income
|
|
0.03
|
|
|
0.10
|
|
|
|
|
0.06
|
|
|
0.35
|
|
|
|
|
Transaction related costs
|
|
0.19
|
|
|
0.30
|
|
|
|
|
0.56
|
|
|
0.65
|
|
|
|
|
Income tax true-up of prior transaction costs
|
|
(0.26
|
)
|
|
—
|
|
|
|
|
(0.26
|
)
|
|
—
|
|
|
|
|
2015 cyber attack litigation settlement
|
|
0.42
|
|
|
—
|
|
|
|
|
0.42
|
|
|
—
|
|
|
|
|
Amortization of other intangible assets
|
|
0.15
|
|
|
0.18
|
|
|
|
|
0.30
|
|
|
0.37
|
|
|
|
|
Penn Treaty assessment costs
|
|
—
|
|
|
—
|
|
|
|
|
0.94
|
|
|
—
|
|
|
|
|
Deferred tax asset write-off from California tax legislation
|
|
—
|
|
|
0.08
|
|
|
|
|
—
|
|
|
0.08
|
|
|
|
|
Tax impact of non-GAAP adjustments
|
|
(0.26
|
)
|
|
(0.18
|
)
|
|
|
|
(0.78
|
)
|
|
(0.61
|
)
|
|
|
|
Rounding Impact
|
|
—
|
|
|
(0.01
|
)
|
|
|
|
0.01
|
|
|
(0.01
|
)
|
|
|
|
Net adjustment items
|
|
0.21
|
|
|
0.42
|
|
|
|
|
1.16
|
|
|
1.25
|
|
|
|
|
Adjusted net income per diluted share
|
|
$
|
3.37
|
|
|
$
|
3.33
|
|
|
1.2
|
%
|
|
$
|
8.05
|
|
|
$
|
6.79
|
|
|
18.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Full Year 2017
|
|
|
|
|
|
|
|
|
|
|
|
Outlook
|
|
|
|
|
|
|
|
|
|
Net income per diluted share
|
|
Greater than $10.35
|
|
|
|
|
|
|
|
|
|
Add / (Subtract):
|
|
|
|
|
|
|
|
|
|
|
|
Net realized (gains)/losses on financial instruments
|
|
(0.09
|
)
|
|
|
|
|
|
|
|
|
|
Other-than-temporary impairment losses recognized in income
|
|
0.06
|
|
|
|
|
|
|
|
|
|
|
Transaction related costs
|
|
0.56
|
|
|
|
|
|
|
|
|
|
|
Income tax true-up of prior transaction costs
|
|
(0.26
|
)
|
|
|
|
|
|
|
|
|
|
2015 cyber attack litigation settlement
|
|
0.42
|
|
|
|
|
|
|
|
|
|
|
Penn Treaty assessment costs
|
|
0.94
|
|
|
|
|
|
|
|
|
|
|
Amortization of other intangible assets
|
|
Approximately $0.60
|
|
|
|
|
|
|
|
|
|
Tax impact of non-GAAP adjustments
|
|
Approximately ($0.88)
|
|
|
|
|
|
|
|
|
|
Net adjustment items
|
|
Approximately $1.35
|
|
|
|
|
|
|
|
|
|
Adjusted net income per diluted share
|
|
Greater than $11.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
Six Months Ended
|
|
|
|
|
|
June 30
|
|
|
|
June 30
|
|
|
|
(In millions)
|
|
2017
|
|
2016
|
|
Change
|
|
2017
|
|
2016
|
|
Change
|
|
Reportable segments operating gain
|
|
$
|
1,227.0
|
|
|
$
|
1,500.2
|
|
|
(18.2
|
)%
|
|
$
|
2,812.4
|
|
|
$
|
3,070.6
|
|
|
(8.4
|
)%
|
|
Net investment income
|
|
200.2
|
|
|
194.9
|
|
|
|
|
407.4
|
|
|
366.0
|
|
|
|
|
Net realized gains/(losses) on financial instruments
|
|
16.2
|
|
|
12.5
|
|
|
|
|
23.5
|
|
|
(112.6
|
)
|
|
|
|
Other-than-temporary impairment losses recognized in income
|
|
(7.2
|
)
|
|
(25.7
|
)
|
|
|
|
(15.3
|
)
|
|
(92.6
|
)
|
|
|
|
Interest expense
|
|
(189.9
|
)
|
|
(185.7
|
)
|
|
|
|
(424.9
|
)
|
|
(372.8
|
)
|
|
|
|
Amortization of other intangible assets
|
|
(40.6
|
)
|
|
(47.9
|
)
|
|
|
|
(82.4
|
)
|
|
(98.3
|
)
|
|
|
|
Income from continuing operations before income tax expense
|
|
$
|
1,205.7
|
|
|
$
|
1,448.3
|
|
|
(16.8
|
)%
|
|
$
|
2,720.7
|
|
|
$
|
2,760.3
|
|
|
(1.4
|
)%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward-Looking Statements
This document contains certain forward-looking information about us
that is intended to be covered by the safe harbor for “forward-looking
statements” provided by the Private Securities Litigation Reform Act of
1995. Forward-looking statements are generally not historical facts.
Words such as “expect,” “feel,” “believe,” “will,” “may,” “should,”
“anticipate,” “intend,” “estimate,” “project,” “forecast,” “plan” and
similar expressions are intended to identify forward-looking statements.
These statements include, but are not limited to: financial projections
and estimates and their underlying assumptions; statements regarding
plans, objectives and expectations with respect to future operations,
products and services; and statements regarding future performance. Such
statements are subject to certain risks and uncertainties, many of which
are difficult to predict and generally beyond our control, that could
cause actual results to differ materially from those expressed in, or
implied or projected by, the forward-looking statements. These risks and
uncertainties include: those discussed and identified in our public
filings with the U.S. Securities and Exchange Commission, or SEC;
increased government participation in, or regulation or taxation of
health benefits and managed care operations, including, but not limited
to, the impact of the Patient Protection and Affordable Care Act and the
Health Care and Education Reconciliation Act of 2010, or Health Care
Reform, and the impact of any future modification, repeal or replacement
of Health Care Reform; trends in health care costs and utilization
rates; our ability to secure sufficient premium rates including
regulatory approval for and implementation of such rates; our
participation in federal and state health insurance exchanges under
Health Care Reform, which have experienced and continue to experience
challenges due to implementation of initial and phased-in provisions of
Health Care Reform, and which entail uncertainties associated with the
mix and volume of business, particularly in our Individual and Small
Group markets, that could negatively impact the adequacy of our premium
rates and which may not be sufficiently offset by the risk apportionment
provisions of Health Care Reform; the ultimate outcome of litigation
between Cigna Corporation (“Cigna”) and us related to the merger
agreement between the parties, including our claim for damages against
Cigna, Cigna’s claim for payment of a termination fee and other damages
against us, and the potential for such litigation to cause us to incur
substantial costs, materially distract management and negatively impact
our reputation and financial positions; our ability to contract with
providers on cost-effective and competitive terms; competitor pricing
below market trends of increasing costs; reduced enrollment, as well as
a negative change in our health care product mix; risks and
uncertainties regarding Medicare and Medicaid programs, including those
related to non-compliance with the complex regulations imposed thereon
and funding risks with respect to revenue received from participation
therein; a downgrade in our financial strength ratings; increases in
costs and other liabilities associated with increased litigation,
government investigations, audits or reviews; medical malpractice or
professional liability claims or other risks related to health care
services provided by our subsidiaries; our ability to repurchase shares
of our common stock and pay dividends on our common stock due to the
adequacy of our cash flow and earnings and other
considerations; non-compliance by any party with the Express Scripts,
Inc. pharmacy benefit management services agreement, which could result
in financial penalties; our inability to meet customer demands, and
sanctions imposed by governmental entities, including the Centers for
Medicare and Medicaid Services; events that result in negative publicity
for us or the health benefits industry; failure to effectively maintain
and modernize our information systems; events that may negatively affect
our licenses with the Blue Cross and Blue Shield Association; state
guaranty fund assessments for insolvent insurers; possible impairment of
the value of our intangible assets if future results do not adequately
support goodwill and other intangible assets; intense competition to
attract and retain employees; unauthorized disclosure of member or
employee sensitive or confidential information, including the impact and
outcome of investigations, inquiries, claims and litigation related to
the cyber attack we reported in February 2015; changes in economic and
market conditions, as well as regulations that may negatively affect our
investment portfolios and liquidity; possible restrictions in the
payment of dividends by our subsidiaries and increases in required
minimum levels of capital and the potential negative effect from our
substantial amount of outstanding indebtedness; general risks associated
with mergers, acquisitions and strategic alliances; various laws and
provisions in our governing documents that may prevent or discourage
takeovers and business combinations; future public health epidemics and
catastrophes; and general economic downturns. Readers are cautioned not
to place undue reliance on these forward-looking statements that speak
only as of the date hereof. We do not undertake to update or revise any
forward-looking statements, except as required by applicable securities
laws. Investors are also advised to carefully review and consider the
various risks and other disclosures discussed in our SEC reports.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170726005341/en/
Source: Anthem, Inc.
Anthem Contacts:
Investor Relations
Will
Feest, 317-488-6057
William.feest@anthem.com
or
Media
Jill
Becher, 414-234-1573
Jill.becher@anthem.com